Checking of safety and efficacy of product

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Indian / Asian male & female subjects.

Healthy subjects (no infectious and evolutive pathology which could make the subject

vulnerable and stop the study, no pathology which could interfere with the study, no symptom

in the process of an exploratory checkup)

Between 30 and 50 years of age.

Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)

Having androgenetic alopecia of class I-2 to I-4 according to Ludwig Scale for females and

class II to III (including III, IIIA and IIIvertex) according to Norwood Hamilton Scale for males.

Exclusion Criteria

For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three

months

Having refused to give his/her assent by not signing the consent form

Taking part in another study liable to interfere with this study

Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area

Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less

than 6 months)

Having a progressive asthma (either under treatment or last fit in the last 2 years)

Being epileptic

Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6

months)

Having cutaneous hypersensitivity

Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products

Following a chronic or intermittent medicinal treatment comprising any of the following

products: aspirin-based products, anti-inflammatories, antihistamines, anti-coagulants,

corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)

Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months

Having changed his/ her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit

Having applied a cosmetic product on the studied areas the first day of the study.

Refusing to follow the restrictions below during the study:

- For female, do not take part in any family planning activities leading to pregnancy and

breastfeeding.

- Do not take part in another study liable to interfere with this study

- Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).

- Do not change his cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit.

- During the study: Do not use other hair care products than the tested products to the studied areas (Only provided test product is allowed).

- The day of the measurements: Hair must be washed with provided neutral shampoo. No other hair care product must be used.

Having naturally fair or white hair

Having a dermatosis on the scalp

Having history of any hormonal problem.

Having surgery history on the scalp (micro transplants …)

Refusing the shaving of an area of the scalp of about 1.5 cm², the first day of the study and several times during the study

Having presented a factor inducing a telogen effluvium in the 3 months preceding the start of the study (important stress, high fever…)

Presenting an acute or chronic general disease or pathology which could have an influence on hair endocrinopathy (diabetes, thyroid…), high blood pressure, renal problems, hepatic problems, known anemia.

Having contact allergy or atopic predisposition.

Having history of medical/surgical events that may significantly affect the study outcome e.g.,h/o typhoid or jaundice etc.